NCT02361164

Brief Summary

The primary objectives are to evaluate relationship between nasopharyngeal microbial colonization and the occurrence of AOM or pneumonia in infants.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2012

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2012

Completed
2.6 years until next milestone

First Submitted

Initial submission to the registry

February 6, 2015

Completed
5 days until next milestone

First Posted

Study publicly available on registry

February 11, 2015

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2016

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2017

Completed
Last Updated

April 9, 2018

Status Verified

April 1, 2018

Enrollment Period

4.2 years

First QC Date

February 6, 2015

Last Update Submit

April 5, 2018

Conditions

Outcome Measures

Primary Outcomes (3)

  • Incidence of respiratory disease (Acute Otitis Media, Acute Respiratory Infection)

    2 years

  • Naso-/oro-Pharyngeal colonization with specific pathogens and microbiota

    2 years

  • Risk factors for recurrent Upper Respiratory Track Infection in terms of bacteria or virus, nutritional and immune status, as well as epidemiological factors

    2 years

Secondary Outcomes (2)

  • Incidence of maternal urogenital infection

    2 years

  • Birth outcome

    2 years

Other Outcomes (2)

  • Evaluation of FUT2/3 polymorphism and association with infant health outcomes

    One time point during the study

  • Incidence of diarrhea and evaluation of gut health in infants

    2 years

Study Arms (1)

Mother/child pair

Mother/child pair.

Eligibility Criteria

Age18 Years - 35 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Community sample

You may qualify if:

  • Age: 18-35 years
  • Parity: any but with history of previous normal delivery
  • Weight: Body Mass Index greater than 18.5 but less than 35
  • Past obstetric history: Uncomplicated pregnancy, unremarkable medical and obstetric conditions
  • Current pregnancy: Uneventful progression of pregnancy
  • General health: Normal health related functional status during pregnancy
  • Singleton pregnancy as determined by clinical examination and/or by ultrasonography
  • Cephalic presentation as determined by abdominal clinical examination
  • Expected to have normal pregnancy related outcome
  • Written informed consent

You may not qualify if:

  • Medical history: Known history of diabetes, hypertension, or any systemic disorder
  • Gynecological history: History of major gynecological problem/treatment
  • Complications in previous pregnancy
  • Previous obstetric cholestasis
  • Previous acute fatty liver disease
  • Conditions during current pregnancy
  • RhD negative mother
  • APH/Placental abruption
  • Placenta Praevia
  • Unstable lie
  • Multiple pregnancy
  • Pregnancy induced hypertension (systolic \> 140 mm of Hg, diastolic \> 90 mm of Hg)
  • Severe pre-eclampsia or eclampsia
  • Gestational diabetes
  • Onstetric cholestasis
  • +5 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

International Center for Diarrheal Disease Research

Dhaka, Bangladesh

Location

Biospecimen

Retention: SAMPLES WITH DNA

Blood samples, clinical samples for bacterial and viral isolates

MeSH Terms

Conditions

Respiratory Tract Infections

Condition Hierarchy (Ancestors)

InfectionsRespiratory Tract Diseases

Study Officials

  • Shafiqul Alam Sarker, M.D.

    International Center for Diarrheal Disease Research, Bangladesh

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 6, 2015

First Posted

February 11, 2015

Study Start

July 1, 2012

Primary Completion

September 1, 2016

Study Completion

March 1, 2017

Last Updated

April 9, 2018

Record last verified: 2018-04

Data Sharing

IPD Sharing
Will not share

Locations